I came up with the oral siosome insulin idea on May 4, 2010. We are trying to move fast on this, and get in veterinary in 3 years. I believe it might take 7 years to get into human medicine. I get frustrated too when I see a child or person who has a disability that I know we could help. I feel down that I can't create something new quickly and help them. I guess the solution is to make drug approval time and procedure faster by making it a key point of elections to the House and Senate. The FDA could move faster if new laws were put into place to expedite things, however we are sue happy society and hence the process we now have.
As a company Helia can't afford the approx. $80M to take this to market. I personally try to do the best I can and use the gifts God gave me. I think that is all I can do. I believe this application, if successful, will be for sale sooner in other countries before the US. Please understand that there are some of us out in the world trying to help and we don't worry about money so much as we do who we can help.
Helia Medical and Siogen Biotech announced today that they have finalized an agreement for the development of a new oral insulin delivery system for type 1 diabetes. The arrangement, which is effective as of July 20, 2010, provides for the development of a Siosome® nanoparticle containing synthetic human insulin designed to be administered orally and then time-released into the bloodstream over a 12-hour period. Financial terms and specific details have not been disclosed.
Under the agreement, Helia Medical and Siogen Biotech shall work together to develop this drug for canine type 1 diabetes. The project shall commence in the third quarter of 2010. The partnership on this project will lead the veterinary and medical world to a new personalized method to manage diabetes in a more controlled and patient-friendly manner.
Siogen Biotech is Malaysia based company that focuses on developing nanoparticle delivery systems for many different drugs, compounds and substances. Siogen is a world leader in the production of silane-based nanoparticles. Siogen's main office is located in Kuala Lumpur, Malaysia and has other facilities in Germany and the UK. www.siogen.com
Helia Medical is a Wisconsin based company with operations in Raleigh, North Carolina. Helia Medical's mission is developing novel and effective drugs, devices and nanoparticles for the veterinary medical world. Helia Medical uses many cutting-edge human medical developments and applies them to veterinary medical applications. www.heliamedical.com
Helia Medical and Siogen Biotech look forward to working together on this project as well as others in the future. Many of the developments from this partnership should directly advance not only veterinary medicine, but also human medicine worldwide.
SOURCE Helia Medical www.heliamedical.com Copyright (C) 2010View Thread